CYTOKINETICS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Cytokinetics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2015 to Q3 2024.
  • Cytokinetics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 118K shares, a 22.5% increase year-over-year.
  • Cytokinetics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 96.5K shares, a 7.46% increase from 2022.
  • Cytokinetics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 89.8K shares, a 16.8% increase from 2021.
  • Cytokinetics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 76.9K shares, a 19.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 118K +21.6K +22.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 109K +13.5K +14.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 102K +6.76K +7.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 96.5K +6.7K +7.46% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 96.1K +2.31K +2.47% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 95.8K +10K +11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 95.2K +10.2K +12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 89.8K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 93.8K +13.4K +16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 85.7K +14K +19.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 85K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q3 2021 80.3K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 71.8K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q3 2017 53.7M* +10.5M Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-03
Q3 2016 43.2M +4.47M +11.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q3 2015 38.8M Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.